Edwards Lifesciences (EW) SVP Andrew Dahl Sells 544 Shares

What Happened
Andrew M. Dahl, SVP and Corporate Controller of Edwards Lifesciences (EW), sold 544 shares in an open-market/ private sale on August 31, 2026. The shares were disposed at $91.06 each, for a total transaction value of approximately $49,534. This was a sale (routine insider selling is common and does not by itself indicate company outlook).

Key Details

• Transaction date: 2026-08-31
• Transaction type/code: Sale (S) — open market or private sale
• Price per share: $91.06; Shares sold: 544; Total value: ~$49,534
• Shares owned after transaction: Not disclosed on this Form 4 (the filing reflects changes only)
• Remarks: Filing notes it "includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan" and that the Form reflects only changes in beneficial ownership
• Filing timeliness: Reported and filed with the SEC on 2026-08-31 (appears timely, not marked late)

Context
This is an officer sale, not an exercise of options or a gift. Sales by executives can be routine (for diversification, tax or liquidity needs); they are informative but should not be taken alone as a signal of company performance. No 10% ownership or derivative transactions are indicated in this filing.